Intravenous Infusions (XGHA:IIL) Price-to-Free-Cash-Flow : (As of Jun. 20, 2024)

View and export this data going back to 2015. Start your Free Trial

What is Intravenous Infusions Price-to-Free-Cash-Flow?

As of today (2024-06-20), Intravenous Infusions's share price is GHS0.05. Intravenous Infusions does not have enough years/quarters to calculate the Free Cash Flow per Share for the trailing twelve months (TTM) ended in . 20. Therefore GuruFocus does not calculate Price-to-Free-Cash-Flow Ratio at this moment.

The historical rank and industry rank for Intravenous Infusions's Price-to-Free-Cash-Flow or its related term are showing as below:

XGHA:IIL's Price-to-Free-Cash-Flow is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 22.66
* Ranked among companies with meaningful Price-to-Free-Cash-Flow only.

Intravenous Infusions's Free Cash Flow per Share for the six months ended in . 20 was GHS0.00.

Intravenous Infusions Price-to-Free-Cash-Flow Historical Data

The historical data trend for Intravenous Infusions's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Intravenous Infusions Price-to-Free-Cash-Flow Chart

Intravenous Infusions Annual Data

Trend

Price-to-Free-Cash-Flow

Intravenous Infusions Semi-Annual Data

Price-to-Free-Cash-Flow

Competitive Comparison of Intravenous Infusions's Price-to-Free-Cash-Flow

For the Drug Manufacturers - Specialty & Generic subindustry, Intravenous Infusions's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Intravenous Infusions's Price-to-Free-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Intravenous Infusions's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Intravenous Infusions's Price-to-Free-Cash-Flow falls into.

Intravenous Infusions Price-to-Free-Cash-Flow Calculation

Intravenous Infusions's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio	=	Share Price	/	Free Cash Flow per Share (TTM)
	=	0.05	/
	=

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio

Market Cap

Free Cash Flow

Intravenous Infusions (XGHA:IIL) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.

Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.

Intravenous Infusions Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Intravenous Infusions's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Intravenous Infusions (XGHA:IIL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Intravenous Infusions Ltd (XGHA:IIL) » Definitions » Price-to-Free-Cash-Flow

Comparable Companies

Traded in Other Exchanges

N/A

Address

Plot 4/7 Blk L, P.O Box KF 63, Effiduase-Koforidua, GHA

Website

https://www.iil.com.gh

Intravenous Infusions Ltd engages in the production of intravenous infusion and small-volume injectables for therapeutic purposes. The product categories are IV fluids, giving sets, and small-volume injectables. The company earns a majority of its revenue from IV fluids. Some of the IV fluids are sodium chloride solutions, dextrose solutions, dextrose saline solutions, and dextran solutions. Small-volume injectables include pethidine injection, magnesium sulphate injection, and quinine injection. Giving sets include plain giving sets, and blood giving sets.